Companies: 10,795·Total market cap: $144.5T
TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFPNASDAQHealthcare
$0.07
$-0.10(-60.05%)
Market Cap$288798
P/E Ratio
52W High$11.0
52W Low$0.061
Overview

TFF Pharmaceuticals, Inc.(TFFP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · TFFP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-122022-122021-122020-122019-12
Revenue
Revenue$0.73M$0.00M$0.00M$0.00M$0.00M
Cost of Revenue$0.50M$0.39M$0.11M$0.00M$0.00M
Gross Profit$0.23M($0.39M)($0.11M)$0.00M$0.00M
Gross Margin %(computed)31.53%
Operating Expenses
R&D Expenses$11.56M$18.50M$21.30M$10.68M$8.82M
G&A Expenses$10.57M$13.80M$10.57M$8.01M$3.17M
Total Operating Expenses$22.13M$31.80M$31.79M$18.69M$11.99M
Operating Income($21.89M)($31.80M)($31.79M)($18.69M)($11.99M)
Operating Margin %(computed)
Interest Income$0.00M$0.03M$0.05M$0.13M$0.12M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($21.24M)($31.77M)($31.04M)($18.57M)($11.87M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($21.24M)($31.77M)($30.99M)($18.44M)($11.75M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-11.85$-26.49$-31.21$-22.57$-42.55
Wtd Avg Shares1.79M1.20M0.99M0.82M0.28M
EBITDA($20.74M)($31.41M)($30.93M)($18.69M)($11.99M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解TFF Pharmaceuticals, Inc.

关于TFF Pharmaceuticals, Inc.(TFFP)损益表

TFF Pharmaceuticals, Inc.(TFFP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,TFFP实现营收$0.00B,毛利润$0.00B(毛利率31.53%),净利润($0.02B)(净利率-2894.68%)。

常见问题

TFFP · 4 问

TFF Pharmaceuticals, Inc.(TFFP)2023财年营收为$0.00B,同比up—%。

TFFP revenueTFFP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09